Early gastric cancer

  • D R Farley
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  • J H Donohue
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  • D M Nagorney
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  • H A Carpenter
    Department of Surgery and Section of Medical Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  • J A Katzmann
    Department of Surgery and Section of Immunopathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  • D M Ilstrup
    Department of Surgery and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

抄録

<jats:title>Abstract</jats:title> <jats:p>Early gastric cancer comprises more than 30 per cent of gastric carcinomas treated in Japan but remains an uncommon entity in the western hemisphere. A retrospective review of 48 patients with early gastric cancer undergoing operative treatment between 1965 and 1984 was carried out. The mean patient age was 70 years, in 31 men and 17 women. Preoperative diagnosis was made in 88 per cent of patients undergoing oesophagogastroduodenoscopy with biopsy but upper gastrointestinal radiography was diagnostic in only 20 per cent. Surgical management consisted of subtotal gastrectomy (86 per cent), total gastrectomy (10 per cent) and wide local excision (4 per cent). The operative mortality and morbidity rates were 0 and 38 per cent, respectively. Mean follow-up was 7.7 years, with 44 per cent of patients still alive. Multivariate analysis disclosed only a healthy. Eastern Cooperative Oncology Group score (P = 0.002) and a diploid DNA tumour pattern (P = 0.05) as significant prognostic variables of survival. The overall survival rate of patients with early gastric cancer (70 per cent at 5 years) was equivalent to that of an age- and sex-matched control population.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ